CR1 and Alzheimer disease: These probe sets targeted transcripts for CASP9 (caspase 9), which was previously highlighted by the analysis in Gomez Ravetti et al. [5], TNKS (tankyrase) and CR1 (complement receptor 1), which is genetically associated with the risk of AD [22], [23], [24], [25], [26], [27], [28], [29], [30] and entorhinal cortex volume in young healthy adults [31] (see also [32]).